Medical outpatient buildings are quietly doing what most of the office market can’t right now: behaving like a “needs-based” product instead of a discretionary one.

Avison Young’s U.S. Medical Outpatient Insights (2H 2025) frames MOBs as the breakout CRE performer because the demand drivers don’t hinge on hybrid-work debates or corporate space cuts. People still age, still need chronic care, still get imaging and procedures, and health systems still push services closer to where patients live. That’s why this niche has kept investor attention even while conventional office is stuck fighting vacancy and rent pressure.

What The Numbers Are Really Saying

A few data points in the report tell a consistent story:

• Capital has poured in over the long run. Annual deal volume grew from $29B (2016) to $154B (2025), per Avison Young. That’s not a short-term blip; it’s a decade-long repricing of the asset class around stability.
• Fewer deals, bigger checks. Transactions fell from a peak of 4,821 (2021) to 2,803 (2025), but pricing power didn’t fade. The “why” is embedded in the shift: larger portfolio trades and more institutional-scale product changing hands, not mom-and-pop single-building deals.
• MOBs separated from office fundamentals. From 2023–2025, office deliveries dropped 54.1% while MOB deliveries dipped only 5.3%. And while office rents slipped 3.4%, MOB rents rose 6.2%. Occupancy tells the same story: 80.2% traditional office vs. 92.3% MOBs by year-end 2025.
• Investors chased them harder. Cap rates compressed from 7.47% (end of 2024) to 6.49% (end of 2025)—a pretty loud signal that more buyers are fighting over the same kind of “safe” income.

If you had to boil it down: MOBs look less like “office” and more like healthcare infrastructure with leases.

Why It Matters (beyond the MOB niche)

This isn’t just a “nice sector” story; it’s a map of where capital thinks the next decade is headed.

1. Healthcare demand is structural. Avison Young points to healthcare hiring pressure: job postings in medical/social assistance rose from 88,630 (mid-2020) to 205,437 (mid-2025). That’s an expansion signal—and it supports occupancy because staffing growth usually tracks service expansion.
2. Investors are paying up for predictability. Cap rate compression in 2025 suggests buyers are willing to accept lower yields for steadier occupancy and rent growth. That reshapes underwriting norms, especially for lenders comparing MOB risk to general office risk.
3. The “office” label is getting unhelpful. When MOB occupancy sits in the 90s and conventional office is hovering around 80%, calling them the same property type can lead to lazy valuation and policy decisions.

What’s Missing (the questions investors should still ask)

The report’s fundamentals are strong, but there are a few gaps that matter in underwriting and local planning:

• Tenant quality and lease structure detail. “Medical office” covers everything from credit health systems to thinly capitalized practices. The spread between a hospital-affiliated clinic lease and a small specialty practice lease can be enormous.
• Reimbursement and policy exposure. Demand is durable, but healthcare economics still run through Medicare/Medicaid dynamics and insurer negotiations. The report emphasizes jobs and occupancy; it doesn’t dig into reimbursement risk.
• New supply isn’t uniform. Deliveries “only” slipping 5.3% nationally can hide pockets where health systems overbuild or where new outpatient campuses cluster and compete.
• Concentration risk in portfolio trades. Fewer, higher-value deals sound bullish, but big portfolios can also mean buyers are taking on more market/tenant concentration in one move.

A Florida (and especially South Florida) Lens

Even without metro-by-metro Florida stats in the excerpt, the implications are pretty direct for this region:

• Population growth + aging demographics amplify the MOB thesis. Florida’s patient base is a demand engine for outpatient, imaging, orthopedics, oncology, and chronic care management. That makes MOB rent growth feel more “utility-like” than cyclical.
• Health system expansion turns into real estate competition. When major systems and physician groups expand footprints, it drives absorption—but it can also create “winner-takes-most” submarkets where proximity to hospitals, highways, and affluent rooftops commands a premium.
• Insurance and staffing realities show up in real estate. Avison Young notes hiring pressure and rising salaries—good for service growth, but it can squeeze smaller practices. That matters because weaker practices can mean more turnover risk unless buildings are anchored by strong credit tenants or health-system adjacency.

Translation for local owners and brokers: in South Florida, the MOB story is less about “office recovery” and more about where healthcare delivery is moving—and which corridors are becoming outpatient hubs.

Who’s Buying—and What That Signals

In 2025, private buyers led MOB acquisitions (51.1%), followed by listed REITs (26.3%) and institutional buyers (9%), according to Avison Young. That mix is telling:

• Private capital is still driving volume—often faster-moving and more opportunistic on deals.
• REIT participation staying high suggests public-market healthcare landlords still believe in the long-run cash-flow story.
• Lower institutional share might reflect pricing: when cap rates compress quickly, some institutions pause until the “new normal” settles.

Bottom line

Avison Young’s data supports a simple takeaway: MOBs are trading like the anti-office office. Higher occupancy, rent growth, and cap-rate compression point to investors treating outpatient real estate as a core defensive allocation—especially as healthcare delivery keeps shifting away from inpatient towers and toward distributed, neighborhood-based care.

If traditional office is still negotiating what demand even is, medical outpatient already has its answer: patients don’t log in from home.

Source:  GlobeSt.